A large fraction of the many monoclonal antibodies available to STn and Tn antigens were elicited with OSM and AOSM as the immunogen, and partially desialylated OSM was used in a clinical trial to stimulate immunity in cancer patients (90). The gene discussed is EEF1A2; the disease is cancer.